Stavzor
Term · Oncology and biomedicine · MLC-T-ONC-008286
A drug used to treat epileptic seizures and bipolar disorder and to prevent migraine headaches. It is also being studied in the treatment of several types of cancer. It blocks an enzyme that cells need to grow and may cause cancer cells to die. It also blocks the growth of new blood vessels that tumors need to grow. It is a type of anticonvulsant, histone deacetylase (HDAC) inhibitor, antimaniacal, migraine headache prophylactic, and antiangiogenesis agent. Also called Depakene and valproic acid.
| Identifier | MLC-T-ONC-008286 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Depakene; valproic acid |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-008286",
"term": "Stavzor",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat epileptic seizures and bipolar disorder and to prevent migraine headaches. It is also being studied in the treatment of several types of cancer. It blocks an enzyme that cells need to grow and may cause cancer cells to die. It also blocks the growth of new blood vessels that tumors need to grow. It is a type of anticonvulsant, histone deacetylase (HDAC) inhibitor, antimaniacal, migraine headache prophylactic, and antiangiogenesis agent. Also called Depakene and valproic acid.",
"synonyms": [
"Depakene",
"valproic acid"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/stavzor/"
}
Record 15,650 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.